Hair Thinning and Hair Loss in Midlife Women
Scalp hair commonly thins during perimenopause and menopause. The causes are multiple, the workup matters, and a careful approach is both safer and more effective than a single off-the-shelf product.
By The HRT Index Editorial Team · Published 2026-05-15 · Last reviewed by editors: 2026-05-26
Editorial research — not medically reviewed by a clinician.
No active affiliate links on this page as of 2026-05-26.
This article is educational and is not medical advice. Consult your clinician before starting, stopping, or changing hormone therapy. Individual responses to HRT vary; the right hormones, doses, and delivery methods for you depend on your medical history and clinical context.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
- What it asks: your symptoms, age and uterus status, medication route preference, insurance or cash-pay situation, and state
- What you get: a personalized shortlist of online HRT providers matched to your situation, with verified pricing, plus a clear flag when online care isn't the right starting point
- Cost: free · about 60 seconds · no signup
The common pattern
The most common pattern in midlife women is diffuse thinning over the top and crown of the scalp, often most noticeable at the part, with the frontal hairline relatively preserved. This is consistent with female-pattern hair loss (androgenetic alopecia), which has a hormonal component that can become more clinically apparent as estradiol declines and the relative androgen effect on the scalp rises.
What actually deserves a workup first
Before any treatment is started, a thoughtful clinician will rule out non-hormonal contributors that frequently coexist in midlife women:
- Iron deficiency (ferritin, not just hemoglobin)
- Thyroid dysfunction
- Vitamin D deficiency
- Recent significant weight loss or low protein intake
- A recent major stressor producing telogen effluvium (a shedding pattern that resolves on its own)
- Scalp conditions (seborrheic dermatitis, lichen planopilaris)
- Medications that contribute to hair loss
Several of these are easily missed and are reversible. Treating androgenetic alopecia without addressing a coexisting iron deficiency, for example, underperforms what would have been possible with the workup done first.
What the evidence supports for treatment
- Topical minoxidil — the strongest non-prescription evidence base for female-pattern hair loss.
- Low-dose oral minoxidil — used off-label with growing evidence; requires clinician oversight for blood pressure and side-effect considerations.
- Spironolactone — an anti-androgen used off-label for female-pattern hair loss, with reasonable evidence in the right patient.
- HRT — has not been shown to be a primary treatment for hair loss, but addressing the broader hormonal picture can help indirectly.
Seek a dermatology evaluation if:
Hair loss is rapid, involves patches, affects eyebrows or eyelashes, is accompanied by scalp symptoms (itch, pain, burning), or does not fit the typical diffuse crown-and-part pattern. Patchy or scarring alopecia requires a different evaluation and treatment approach than androgenetic alopecia.
Where to start
For midlife women whose hair complaint is part of a broader perimenopausal picture, one of the comprehensive-care telehealth practices that can coordinate HRT with adjacent prescribing (Alloy in particular) is usually a better starting point than a standalone hair-loss service. For patients with isolated androgenetic alopecia and no broader symptom picture, a dermatology-led practice will go deeper on the workup. See the provider comparison for trade-offs.
Sources used for this guide
This guide was editorially checked against current materials from The Menopause Society, relevant dermatology literature on androgenetic alopecia and female-pattern hair loss, and FDA labeling for topical and oral treatments discussed.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
Find My HRT Path →